Immunotherapy Stocks List

Recent Signals

Date Stock Signal Type
2019-11-15 ADAP New 52 Week Closing Low Bearish
2019-11-15 ADAP New 52 Week Low Weakness
2019-11-15 AIMT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-15 AIMT NR7 Range Contraction
2019-11-15 APTO Calm After Storm Range Contraction
2019-11-15 APTO Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-15 ARDS New 52 Week Low Weakness
2019-11-15 ARDS New 52 Week Closing Low Bearish
2019-11-15 ARGX Upper Bollinger Band Walk Strength
2019-11-15 ARGX NR7 Range Contraction
2019-11-15 BLCM Calm After Storm Range Contraction
2019-11-15 BLCM Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-11-15 BLCM 20 DMA Resistance Bearish
2019-11-15 CDMO 50 DMA Resistance Bearish
2019-11-15 CDMO 20 DMA Resistance Bearish
2019-11-15 CDMO Bollinger Band Squeeze Range Contraction
2019-11-15 CDMOP Expansion Pivot Buy Setup Bullish Swing Setup
2019-11-15 CDMOP Crossed Above 50 DMA Bullish
2019-11-15 CDMOP Stochastic Reached Overbought Strength
2019-11-15 CLBS Upper Bollinger Band Walk Strength
2019-11-15 CLBS Spinning Top Other
2019-11-15 CLBS Calm After Storm Range Contraction
2019-11-15 CLDX Calm After Storm Range Contraction
2019-11-15 CLDX 50 DMA Resistance Bearish
2019-11-15 CVM Pocket Pivot Bullish Swing Setup
2019-11-15 CVM Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-11-15 CVM Bollinger Band Squeeze Range Contraction
2019-11-15 DBVT 20 DMA Support Bullish
2019-11-15 DBVT Pocket Pivot Bullish Swing Setup
2019-11-15 DBVT Bollinger Band Squeeze Range Contraction
2019-11-15 DTIL Upper Bollinger Band Walk Strength
2019-11-15 DTIL Parabolic Rise Strength
2019-11-15 DTIL Pocket Pivot Bullish Swing Setup
2019-11-15 DTIL Calm After Storm Range Contraction
2019-11-15 DTIL Volume Surge Other
2019-11-15 ENLV Narrow Range Bar Range Contraction
2019-11-15 ENLV Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-11-15 FBIO Wide Range Bar Range Expansion
2019-11-15 FBIO Pocket Pivot Bullish Swing Setup
2019-11-15 FBIO Upper Bollinger Band Walk Strength
2019-11-15 FBIO Crossed Above 200 DMA Bullish
2019-11-15 FBIOP Cup with Handle Other
2019-11-15 FBIOP Wide Range Bar Range Expansion
2019-11-15 FBIOP MACD Bearish Signal Line Cross Bearish
2019-11-15 FBIOP 20 DMA Support Bullish
2019-11-15 FBIOP Upper Bollinger Band Walk Strength
2019-11-15 FBIOP Spinning Top Other
2019-11-15 GNCA Lower Bollinger Band Walk Weakness
2019-11-15 HARP Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-11-15 HARP Bollinger Band Squeeze Range Contraction
2019-11-15 HARP Crossed Above 20 DMA Bullish
2019-11-15 IMRN NR7 Range Contraction
2019-11-15 IMRN Narrow Range Bar Range Contraction
2019-11-15 IMRN 1,2,3 Pullback Bullish Bullish Swing Setup
2019-11-15 IMRN MACD Bearish Signal Line Cross Bearish
2019-11-15 IMRN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-15 IMUX Lower Bollinger Band Walk Weakness
2019-11-15 IMUX Hammer Candlestick Bullish
2019-11-15 INMB Pocket Pivot Bullish Swing Setup
2019-11-15 IOVA 180 Bullish Setup Bullish Swing Setup
2019-11-15 IOVA Calm After Storm Range Contraction
2019-11-15 IOVA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-15 IPHA Hot IPO Pullback Bullish Swing Setup
2019-11-15 IPHA Narrow Range Bar Range Contraction
2019-11-15 JNCE Parabolic Rise Strength
2019-11-15 JNCE Upper Bollinger Band Walk Strength
2019-11-15 JNCE Calm After Storm Range Contraction
2019-11-15 LCTX Pocket Pivot Bullish Swing Setup
2019-11-15 LCTX Crossed Above 20 DMA Bullish
2019-11-15 LCTX MACD Bullish Signal Line Cross Bullish
2019-11-15 LCTX Wide Range Bar Range Expansion
2019-11-15 LCTX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-11-15 LCTX 50 DMA Resistance Bearish
2019-11-15 MBIO Crossed Above 20 DMA Bullish
2019-11-15 MBIO Slingshot Bearish Bearish Swing Setup
2019-11-15 MBIO Pocket Pivot Bullish Swing Setup
2019-11-15 MBIO Bollinger Band Squeeze Range Contraction
2019-11-15 MRKR Lower Bollinger Band Walk Weakness
2019-11-15 MRKR New 52 Week Low Weakness
2019-11-15 MRKR Calm After Storm Range Contraction
2019-11-15 NLNK 180 Bearish Setup Bearish Swing Setup
2019-11-15 NLNK Fell Below 20 DMA Bearish
2019-11-15 NLNK Fell Below 50 DMA Bearish
2019-11-15 NLNK Bollinger Band Squeeze Range Contraction
2019-11-15 NLNK Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-11-15 NXTC 50 DMA Support Bullish
2019-11-15 NXTC Calm After Storm Range Contraction
2019-11-15 NXTC Narrow Range Bar Range Contraction
2019-11-15 NXTC Volume Surge Other
2019-11-15 ONCS Lower Bollinger Band Walk Weakness
2019-11-15 PDSB Lower Bollinger Band Walk Weakness
2019-11-15 PDSB Expansion Breakdown Bearish Swing Setup
2019-11-15 PDSB New 52 Week Low Weakness
2019-11-15 PDSB New 52 Week Closing Low Bearish
2019-11-15 PDSB Stochastic Buy Signal Bullish
2019-11-15 RCUS 20 DMA Resistance Bearish
2019-11-15 RCUS MACD Bearish Signal Line Cross Bearish
2019-11-15 REPL Lower Bollinger Band Walk Weakness
2019-11-15 REPL Volume Surge Other
2019-11-15 REPL Fell Below 200 DMA Bearish
2019-11-15 REPL Stochastic Reached Oversold Weakness
2019-11-15 SELB Calm After Storm Range Contraction
2019-11-15 SELB Narrow Range Bar Range Contraction
2019-11-15 SURF Stochastic Reached Overbought Strength
2019-11-15 TCRR MACD Bullish Centerline Cross Bullish
2019-11-15 TCRR NR7 Range Contraction
2019-11-15 TCRR Narrow Range Bar Range Contraction
2019-11-15 TCRR Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-11-15 UMRX Lower Bollinger Band Walk Weakness
2019-11-15 UMRX New 52 Week Closing Low Bearish
2019-11-15 UMRX Volume Surge Other
2019-11-15 UMRX New 52 Week Low Weakness
2019-11-15 UMRX Reversal New Lows Setup Bearish Swing Setup

Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.

More about Immunotherapy